Last reviewed · How we verify
ActivBiotics Pharma, LLC — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
2 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Infectious diseases · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ain Shams Maternity Hospital · 1 shared drug class
- Baqiyatallah Medical Sciences University · 1 shared drug class
- Celltrion · 1 shared drug class
- Copenhagen Studies on Asthma in Childhood · 1 shared drug class
- Grünenthal GmbH · 1 shared drug class
- Lihir Medical Centre · 1 shared drug class
- London School of Hygiene and Tropical Medicine · 1 shared drug class
- Abbott · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for ActivBiotics Pharma, LLC:
- ActivBiotics Pharma, LLC pipeline updates — RSS
- ActivBiotics Pharma, LLC pipeline updates — Atom
- ActivBiotics Pharma, LLC pipeline updates — JSON
Cite this brief
Drug Landscape (2026). ActivBiotics Pharma, LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/activbiotics-pharma-llc. Accessed 2026-05-16.